MedifastMED -2.45%69 Median PS Value is $51.10 as of Jun. 25, 2026, which is 4588% above its 10-year median of 1.09. GuruFocus rates MED with a GF Score™ of 69/100 and a GF Value™ of $8.75 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 43 Personal Services companies, Medifast ranks better than 93.02% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Medifast's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $31.419. Medifast's 10-Year median PS Ratio is 1.6264. Therefore, the Median PS Value for today is $51.10.
As of today (2026-06-25), Medifast's share price is $10.36. Medifast's Median PS Value is $51.10. Therefore, Medifast's Price to Median PS Value for today is 0.20.
The historical rank and industry rank for Medifast's Median PS Value or its related term are showing as below:
MED'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.17 Med: 1.09 Max: 4.43
Current: 0.2
During the past 13 years, the highest Price to Median PS Value of Medifast was 4.43. The lowest was 0.17. And the median was 1.09.
MED's Price-to-Median-PS-Value is ranked better than 93.02% of 43
companies
in the Personal Services industry
Industry Median: 0.89
vs MED: 0.20
Medifast (NYSE:MED) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Medifast's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
10.36
/
51.10
=
0.20
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast Median PS Value Related Terms
Medifast Median PS Value Historical Data
* Premium members only.
The historical data trend for Medifast's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MED vs RGS, VGES, EVTK: Median PS Value Comparison
For the Personal Services subindustry, Medifast's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast Price-to-Median-PS-Value vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Medifast's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.6264.
Medifast's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $31.419.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast (MED) has a Median PS Value of $51.10 as of Jun. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Medifast and its competitors. This is 4588% above median its historical median of 1.09. Over the past decade, Medifast's Median PS Value has ranged from 0.17 to 4.43. According to the industry distribution chart, Medifast ranks #3 out of 43 companies in the Personal Services industry, placing it in the top 7%.
Is Medifast's Median PS Value too high?
Medifast's current Median PS Value of $51.10 is 4588% above median its 10-year median of 1.09. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 4.43. The Personal Services industry median Median PS Value is 0.89. Medifast's value of $51.10 is 5641.6% above this industry median. Based on the distribution chart, Medifast ranks #3 out of 43 companies in the Personal Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medifast has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's Median PS Value compare to RGS and VGES?
According to the Personal Services industry distribution chart, Medifast ranks #3 out of 43 companies for Median PS Value. This places Medifast in the top 7% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.89. Medifast's value of $51.10 is 5641.6% above this benchmark. Historically, Medifast's own Median PS Value has ranged from 0.17 to 4.43 over the past decade. While the company's 10-year median is 1.09 vs. the industry median of 0.89, Medifast has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Personal Services company?
The median Median PS Value among Personal Services companies is 0.89, based on 43 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medifast's current Median PS Value of $51.10 is 5641.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Medifast and its competitors. For the Personal Services industry, the median Median PS Value is 0.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medifast's current Median PS Value is $51.10, which is 4588% above median its own 10-year median of 1.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (MED) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.75, compared to a current price of $10.36 — trading 18.4% above its estimated fair value. The current Median PS Value is $51.10, which is 4588% above median its 10-year median of 1.09 and 5641.6% above the Personal Services industry median of 0.89. Medifast's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Medifast (MED), the current Median PS Value is $51.10 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medifast (MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medifast stock appears to be overvalued.
The current stock price of $10.36 is trading 18.4% above its estimated GF Value™ of $8.75.
GuruFocus considers Medifast to be Modestly Overvalued.
Key valuation signals for MED:
Median PS Value: $51.10 (4588% above median its 10-year median of 1.09)
GF Value™: $8.75 vs. price of $10.36 (18.4% above fair value)
Industry Position: 5641.6% above the Personal Services median (#3 of 43)
No single metric tells the full story. See the MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
69GF Score
Get the complete analysis for MED
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MED has been successfully added to your 
